Title : Pioglitazone lowers serum retinol binding protein 4 by suppressing its expression in adipose tissue of obese rats.

Pub. Date : 2015

PMID : 25634757






7 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Pioglitazone lowers serum retinol binding protein 4 by suppressing its expression in adipose tissue of obese rats. Pioglitazone retinol binding protein 4 Rattus norvegicus
2 We investigated whether, and how, pioglitazone modulates serum level of retinol binding protein 4 (RBP4), an adipocytokine associated with obesity and insulin resistance. Pioglitazone retinol binding protein 4 Rattus norvegicus
3 We investigated whether, and how, pioglitazone modulates serum level of retinol binding protein 4 (RBP4), an adipocytokine associated with obesity and insulin resistance. Pioglitazone retinol binding protein 4 Rattus norvegicus
4 RESULTS: Pioglitazone treatment significantly decreased serum RBP4 levels in obese rats, which was correlated with reduced body weight and increased insulin sensitivity. Pioglitazone retinol binding protein 4 Rattus norvegicus
5 Moreover, pioglitazone greatly decreased RBP4 mRNA and protein levels in adipose tissue but not in the liver. Pioglitazone retinol binding protein 4 Rattus norvegicus
6 CONCLUSION: These results demonstrate that pioglitazone inhibits the level of serum RPB4 by suppressing RBP4 expression in adipose tissue of obese rats, suggesting that inhibiting RBP4 expression in adipocytes may provide a mechanism by which pioglitazone improves insulin sensitivity in insulin-resistant subjects. Pioglitazone retinol binding protein 4 Rattus norvegicus
7 CONCLUSION: These results demonstrate that pioglitazone inhibits the level of serum RPB4 by suppressing RBP4 expression in adipose tissue of obese rats, suggesting that inhibiting RBP4 expression in adipocytes may provide a mechanism by which pioglitazone improves insulin sensitivity in insulin-resistant subjects. Pioglitazone retinol binding protein 4 Rattus norvegicus